| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 08/05/2014 | CA2677703C Methods of correcting imbalance between bone resorption and bone formation and kits and compositions therefor |
| 08/05/2014 | CA2663234C Novel phenylacetic acid derivative |
| 08/05/2014 | CA2661333C Salt of phenoxypyridine derivative or crystal thereof and process for producing the same |
| 08/05/2014 | CA2654987C Substituted aminopyrazolopyridines and salts thereof, their preparations and pharmaceutical compositions comprising them |
| 08/05/2014 | CA2654789C Substituted aminopyrazolopyridines and salts thereof, their preparations and pharmaceutical compositions comprising them |
| 08/05/2014 | CA2654439C Salts of n-hydroxy-3-[4-[[[2-(2-methyl-1h-indol-3-yl)ethyl]amino]methyl]phenyl]-2e-2-propenamide |
| 08/05/2014 | CA2654105C Substituted arylpyrazolopyridines and salts thereof, pharmaceutical compositions comprising same, methods of preparing same and uses of same |
| 08/05/2014 | CA2649269C Protein complex and process for producing the same |
| 08/05/2014 | CA2643488C Indolopyridines as eg5 kinesin modulators |
| 08/05/2014 | CA2630551C N-hydroxyamide derivatives and use thereof |
| 08/05/2014 | CA2629244C Quinazoline derivatives for the treatment of cancer diseases |
| 08/05/2014 | CA2597430C Isoxazole combretastin derivatives for the treatment of disorders |
| 08/05/2014 | CA2505316C Single domain antibodies directed against tumour necrosis factor-alpha and uses therefor |
| 08/05/2014 | CA2497792C Cyclodextrin-based polymers for therapeutics delivery |
| 08/05/2014 | CA2486649C Fusion protein comprising angiopoietin receptor-binding and a multimerization domain |
| 08/05/2014 | CA2465325C Antibodies for inhibiting blood coagulation and methods of use thereof |
| 08/05/2014 | CA2347099C Adjuvant systems comprising an immunostimulant adsorbed to a metallic salt particle and vaccines thereof |
| 07/31/2014 | WO2014117090A1 Metalloenzyme inhibitor compounds |
| 07/31/2014 | WO2014116962A1 Selective histone deacetylase 8 inhibitors |
| 07/31/2014 | WO2014116704A1 Phosphoribosyl pyrophosphate synthetase 2 (prps2) as a therapeutic target in cancer treatment |
| 07/31/2014 | WO2014116573A1 Processes for the preparation of isotopologues of 3-(4-((4-(morpholinomethyl)benzyl)oxy)-1-oxoisoindolin-2-yl)piperidine-2,6-dione and pharmaceutically acceptable salts thereof |
| 07/31/2014 | WO2014116386A1 (22E)-2-METHYLENE-22-DEHYDRO-1α,24,25-TRIHYDROXY-19-NOR-VITAMIN D3 ANALOGS |
| 07/31/2014 | WO2014116070A1 Method for preparing 1-(4-(4-(3,4-dichloro-2-fluorophenylamino)-7-methoxyquinazolin-6-yloxy)piperidin-1-yl)prop-2-en-1-one |
| 07/31/2014 | WO2014115126A1 Heat-sensitive nanoparticle system |
| 07/31/2014 | WO2014115080A1 Pyrazolo[3,4-d]pyrimidinone compounds as inhibitors of the p53/mdm2 interaction |
| 07/31/2014 | WO2014115020A1 Heterocycles and their radiolabeled analogs useful as cox-1 selective inhibitors |
| 07/31/2014 | WO2014114971A1 Increased dosage of efavirenz for the treatment of cancer |
| 07/31/2014 | WO2014114928A1 Chemical compounds |
| 07/31/2014 | WO2014114801A1 Antibodies targeting cdh19 for melanoma |
| 07/31/2014 | WO2014114800A1 Antibody constructs for cdh19 and cd3 |
| 07/31/2014 | WO2014114732A1 Inorganic nanoparticles compositions in combination with ionizing radiations for treating cancer |
| 07/31/2014 | WO2014114575A1 Pharmaceutical composition with improved bioavailability |
| 07/31/2014 | WO2014079545A8 Thioether derivatives as protein kinase inhibitors |
| 07/31/2014 | WO2013117288A8 Tetrahydro-quinazolinone derivatives as tank and parp inhibitors |
| 07/31/2014 | WO2013082624A3 Materials and methods related to nsaid chemoprevention in colorectal cancer |
| 07/31/2014 | US20140213532 Compositions and methods for enhancing drug delivery across and into epithelial tissues |
| 07/31/2014 | US20140212972 Process for producing cytotoxic lymphocyte |
| 07/31/2014 | US20140212969 Nucleic Acids, Polypetides, and Methods for Modulating Apoptosis |
| 07/31/2014 | DE102013201495A1 Mittel zur Hemmung unerwünschten Zellwachstums Means for inhibiting unwanted cellular growth |
| 07/31/2014 | DE102013001636A1 Pharmazeutische Zusammensetzung umfassend Leflunomid A pharmaceutical composition comprising leflunomide |
| 07/30/2014 | EP2759547A1 Platinum compound having amino- or alkylamino-containing succinic acid derivatives as leaving group, preparation method therefor, and use thereof |
| 07/30/2014 | EP2759304A1 Fungal immunomodulatory protein for use in the treatment of cancer |
| 07/30/2014 | EP2759297A1 Combination therapy using p53 activator and c-Met inhibitor |
| 07/30/2014 | EP2758437A2 Cd27l antigen binding proteins |
| 07/30/2014 | EP2758418A1 Crystallization of idarubicin hydrochloride |
| 07/30/2014 | EP2758402A1 Pyrrolopyrimidine and purine derivatives |
| 07/30/2014 | EP2758401A1 Amino-substituted imidazopyridazines |
| 07/30/2014 | EP2758400A1 Substituted imidazopyridazines |
| 07/30/2014 | EP2758395A1 Compounds useful as inhibitors of choline kinase |
| 07/30/2014 | EP2758392A1 Use of strigolactones and strigolactone analogs for treating proliferative conditions |
| 07/30/2014 | EP2758389A1 Pyrazole carboxamides as janus kinase inhibitors |
| 07/30/2014 | EP2758387A1 Pyridine compounds as inhibitors of kinase |
| 07/30/2014 | EP2758384A1 Phenylimide-containing benzothiazole derivative or its salt and pharmaceutical composition comprising the same |
| 07/30/2014 | EP2758380A1 Benzoic acid derivatives as eif4e inhibitors |
| 07/30/2014 | EP2758379A1 Morpholino substituted urea or carbamate derivatives as mtor inhibitors |
| 07/30/2014 | EP2758377A1 Cycloalkylnitrile pyrazole carboxamides as janus kinase inhibitors |
| 07/30/2014 | EP2758371A1 New thio derivatives bearing lactams as potent hdac inhibitors and their uses as medicaments |
| 07/30/2014 | EP2758370A1 Parp inhibitors |
| 07/30/2014 | EP2758367A1 Novel isocyanate and isothiocyanate compounds for cancer treatment |
| 07/30/2014 | EP2758080A1 Cancer immunotherapy |
| 07/30/2014 | EP2758067A1 Romidepsin and 5 - azacitidine for use in treating lymphoma |
| 07/30/2014 | EP2758052A2 Pharmaceutical compositions |
| 07/30/2014 | EP2758043A2 Compositions and methods to improve the therapeutic benefit of suboptimally administered chemical compounds including substituted hexitols such as dibromodulcitol |
| 07/30/2014 | CN103958541A 5α-羟基-6β-[2-(1H-咪唑-4-基)乙基氨基]胆甾烷-3β-醇的酸加成盐 5α- hydroxy -6β- [2- (1H- imidazol-4-yl) ethylamino] The acid addition salts of cholesteryl alkyl alcohol -3β- |
| 07/30/2014 | CN103958515A 氨基取代的咪唑并哒嗪 Amino-substituted imidazo pyridazine |
| 07/30/2014 | CN103958513A 6-羟基嘌呤衍生物盐酸盐 6-hydroxy purine derivative hydrochloride |
| 07/30/2014 | CN103958512A 3,5-双取代炔基苯化合物及其盐 3,5-disubstituted phenyl acetylene compound and the salt |
| 07/30/2014 | CN103958509A 作为酪氨酸激酶抑制剂的6-取代的3-(喹啉-6-基硫代)-[1,2,4]三唑并[4,3-a]吡啶化合物 As the tyrosine kinase inhibitors 6-substituted-3- (quinolin-6-yl-thio) - [1,2,4] triazolo [4,3-a] pyridine compounds |
| 07/30/2014 | CN103958507A 可用作atr激酶抑制剂的化合物 Compounds useful as kinase inhibitors atr |
| 07/30/2014 | CN103958506A 用作突变idh抑制剂的3-嘧啶-4-基-噁唑烷-2-酮化合物 Is used as an inhibitor of 3 mutations idh pyrimidin-4-yl - oxazolidin-2-one compounds |
| 07/30/2014 | CN103958505A 用于治疗趋化因子介导的病理的二取代的3,4-二氨基-3-环丁烯-1,2-二酮化合物 For the treatment of chemokine-mediated pathologies disubstituted 3,4-diamino-3-cyclobutene-1,2-dione compound |
| 07/30/2014 | CN103958502A 作为丝氨酸/苏氨酸激酶抑制剂的喹唑啉化合物 As a serine / threonine kinase inhibitor quinazoline compounds |
| 07/30/2014 | CN103958500A 蛋白激酶抑制剂 Protein kinase inhibitors |
| 07/30/2014 | CN103958497A 作为AXL和c-MET激酶抑制剂的尿嘧啶衍生物 AXL uracil derivatives and c-MET kinase inhibitors |
| 07/30/2014 | CN103958489A 制备卡巴他赛中间体的方法 Cabazitaxel intermediates prepared |
| 07/30/2014 | CN103958487A 作为eif4e抑制剂的苯甲酸衍生物 As a benzoic acid derivative eif4e inhibitors |
| 07/30/2014 | CN103958483A 厄洛替尼盐 Erlotinib salt |
| 07/30/2014 | CN103958479A 吡唑并喹啉酮衍生物、其制备和其治疗用途 Pyrazolo quinoline derivatives, their preparation and their therapeutic use |
| 07/30/2014 | CN103958474A 作为lsd1抑制剂的（杂）芳基环丙基胺化合物 As (hetero) aryl-cyclopropyl amine compounds lsd1 inhibitors |
| 07/30/2014 | CN103958457A 鞘氨醇类似物、组合物及其相关方法 Sphingosine analogues, compositions and related methods |
| 07/30/2014 | CN103957943A 纳米颗粒肿瘤疫苗 Nanoparticles tumor vaccine |
| 07/30/2014 | CN103957941A 用于治疗试剂的靶向递送的模块式转运平台 Modular platform for the transport of the targeted delivery of therapeutic agents |
| 07/30/2014 | CN103957939A 癌症免疫治疗 Cancer immunotherapy |
| 07/30/2014 | CN103957938A 治疗多发性骨髓瘤相关障碍的抗icam-1抗体 Treatment of multiple myeloma-related disorders anti-icam-1 antibody |
| 07/30/2014 | CN103957930A 癌症治疗用疫苗制剂 Vaccine formulation for cancer treatment |
| 07/30/2014 | CN103957925A 具有γ干扰素的抗原呈递癌症疫苗 IFN-γ has an antigen-presenting cancer vaccine |
| 07/30/2014 | CN103957924A 促红细胞生成素衍生肽及其用途 Erythropoietin-derived peptides and their uses |
| 07/30/2014 | CN103957923A 用于抑制包括癌干细胞在内的干细胞的增殖、发育或分化的hs.459642单基因簇产物的拮抗剂 Hs.459642 product of a single gene cluster comprising an antagonist for inhibiting the proliferation of cancer stem cells, including stem cells, development or differentiation |
| 07/30/2014 | CN103957917A 用atr抑制剂治疗胰腺癌和非小细胞肺癌 By atr inhibitor treatment of pancreatic cancer and non-small cell lung cancer |
| 07/30/2014 | CN103957912A 疏水性喜树碱衍生物的药物组合物 The pharmaceutical composition of the hydrophobic derivative of camptothecin |
| 07/30/2014 | CN103952443A 以hTERT为靶点的肿瘤治疗性腺病毒疫苗 HTERT as a target in cancer therapy adenovirus vaccine |
| 07/30/2014 | CN103952440A 一种含人Rad51C启动子的载体及其应用 People Rad51C promoter containing vector and its application |
| 07/30/2014 | CN103952406A 抑制人恶性脑胶质瘤增殖的靶向STAT3基因的siRNA及其表达载体和应用 SiRNA inhibited the proliferation of human malignant glioma targeting STAT3 gene and its expression vector and application |
| 07/30/2014 | CN103952384A 内切型硫酸软骨素/硫酸皮肤素4-o-硫酸酯酶及其编码基因与应用 Endo-sulfated chondroitin / dermatan sulfate sulfatase 4-o- its coding gene and application |
| 07/30/2014 | CN103952367A 一种发酵培养基及利用其生产黑色素瘤治疗性质粒DNA疫苗pSVK-CAVA的方法 A method of fermentation medium and the use of its production melanoma treatment plasmid DNA vaccine pSVK-CAVA's |
| 07/30/2014 | CN103951801A 四氨基苯基卟啉-聚n-异丙基丙烯酰胺-聚甲基丙烯酸n,n-二甲氨基乙酯 Four aminophenyl porphyrin - Poly n- isopropylacrylamide - polymethacrylic acid n, n- dimethylaminoethyl acrylate |
| 07/30/2014 | CN103951766A 聚合物、光响应胶束、光响应载药胶束及其制备方法 Polymer optical response micelles, light response micelles and its preparation method |
| 07/30/2014 | CN103951760A 一种蜈蚣藻寡糖及其制备方法和应用 One kind of centipede algae oligosaccharide and its preparation method and application |
| 07/30/2014 | CN103951756A TAT与PR domain的融合蛋白及其在制备抗肿瘤药物中的应用 TAT and PR domain fusion protein and its application in the preparation of antineoplastic |
| 07/30/2014 | CN103951754A 一种靶向治疗和检测双功能的抗肿瘤双特异性小型化抗体 One kind of targeted therapy and detection bifunctional antitumor bispecific antibody miniaturization |